Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
- 12 March 2004
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 22 (9-10), 1320-1326
- https://doi.org/10.1016/j.vaccine.2003.06.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador.Revista Panamericana de Salud Pública, 2001
- Field Trial of a Vaccine against New World Cutaneous Leishmaniasis in an At‐Risk Child Population: Safety, Immunogenicity, and Efficacy during the First 12 Months of Follow‐UpThe Journal of Infectious Diseases, 1998
- Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in BrazilMemórias do Instituto Oswaldo Cruz, 1998
- Vaccines against leishmaniasisPathogens and Global Health, 1995
- Leishmaniases of the New World: current concepts and implications for future researchClinical Microbiology Reviews, 1993
- Concentration of Pentostam® in human breast milkTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future StrategiesClinical Infectious Diseases, 1988
- Further trials of a vaccine against American cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- Electrocardiographic changes during Treatment of Leishmaniasis with Pentavalent Antimony (Sodium Stibogluconate) *The American Journal of Tropical Medicine and Hygiene, 1985
- An experimental vaccine against American dermal leishmaniasis: experience in the State of Espírito Santo, BrazilPathogens and Global Health, 1985